Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis Bujanda

Showing results (391-400 of 423) with videos related to

Pageof 43
Sort By:
Digestive Diseases (Basel, Switzerland)|March 7, 2024
Evaluation of Genetic Variants Associated with the Risk of Thiopurine-Related Pancreatitis: A Case Control Study from ENEIDA RegistryIván Guerra, Francisco Barros, María Chaparro, et al.
Helicobacter|February 9, 2026
Long-Term Effect of Macrolides on Helicobacter pylori Eradication: Data From the European Registry on Helicobacter pylori Management (Hp-EuReg)Olga P Nyssen, Guillermo J Ortega, Laimas Jonaitis, et al.
Journal of Crohn'S & Colitis|November 6, 2023
Initial Management of Intra-abdominal Abscesses and Preventive Strategies for Abscess Recurrence in Penetrating Crohn's Disease: A National, Multicentre Study Based on ENEIDA RegistryDiego Casas Deza, Cristina Polo Cuadro, Ruth de Francisco, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 5, 2024
Persistence, effectiveness and safety of ustekinumab and vedolizumab therapy for complex perianal fistula in Crohn's disease: The HEAL study from GETECCUMaría José Casanova, Berta Caballol, María José García, et al.
Cancer Medicine|September 8, 2018
Evidence for PTGER4, PSCA, and MBOAT7 as risk genes for gastric cancer on the genome and transcriptome levelSophie K M Heinrichs, Timo Hess, Jessica Becker, et al.
Alimentary Pharmacology & Therapeutics|July 5, 2025
Effectiveness and Safety of First-Line Non-Bismuth Quadruple Concomitant Therapy Versus Single-Capsule Bismuth Quadruple TherapyOlga P Nyssen, Nuria Montes, Ángeles Pérez-Aísa, et al.
Journal of Crohn'S & Colitis|February 1, 2022
Management and Long-term Outcomes of Crohn's Disease Complicated with Enterocutaneous Fistula: ECUFIT Study from GETECCUManuel Barreiro-de Acosta, Sabino Riestra, Margalida Calafat, et al.
Therapeutic Advances in Gastroenterology|January 8, 2024
Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registryMargalida Calafat, Paola Torres, Joan Tosca-Cuquerella, et al.
Gut|July 19, 2023
Bismuth quadruple three-in-one single capsule three times a day increases effectiveness compared with the usual four times a day schedule: results from the European Registry on <i>Helicobacter pylori</i> Management (Hp-EuReg)Ángeles Pérez-Aisa, Olga P Nyssen, Alma Keco-Huerga, et al.
Frontiers in Medicine|February 18, 2022
Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native PatientsAna Gutiérrez, Pedro Zapater, Elena Ricart, et al.
Pageof 43

Showing results (391-400 of 423) with videos related to

Sort By:
Pageof 43
Digestive Diseases (Basel, Switzerland)|March 7, 2024
Evaluation of Genetic Variants Associated with the Risk of Thiopurine-Related Pancreatitis: A Case Control Study from ENEIDA RegistryIván Guerra, Francisco Barros, María Chaparro, et al.
Helicobacter|February 9, 2026
Long-Term Effect of Macrolides on Helicobacter pylori Eradication: Data From the European Registry on Helicobacter pylori Management (Hp-EuReg)Olga P Nyssen, Guillermo J Ortega, Laimas Jonaitis, et al.
Journal of Crohn'S & Colitis|November 6, 2023
Initial Management of Intra-abdominal Abscesses and Preventive Strategies for Abscess Recurrence in Penetrating Crohn's Disease: A National, Multicentre Study Based on ENEIDA RegistryDiego Casas Deza, Cristina Polo Cuadro, Ruth de Francisco, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 5, 2024
Persistence, effectiveness and safety of ustekinumab and vedolizumab therapy for complex perianal fistula in Crohn's disease: The HEAL study from GETECCUMaría José Casanova, Berta Caballol, María José García, et al.
Cancer Medicine|September 8, 2018
Evidence for PTGER4, PSCA, and MBOAT7 as risk genes for gastric cancer on the genome and transcriptome levelSophie K M Heinrichs, Timo Hess, Jessica Becker, et al.
Alimentary Pharmacology & Therapeutics|July 5, 2025
Effectiveness and Safety of First-Line Non-Bismuth Quadruple Concomitant Therapy Versus Single-Capsule Bismuth Quadruple TherapyOlga P Nyssen, Nuria Montes, Ángeles Pérez-Aísa, et al.
Journal of Crohn'S & Colitis|February 1, 2022
Management and Long-term Outcomes of Crohn's Disease Complicated with Enterocutaneous Fistula: ECUFIT Study from GETECCUManuel Barreiro-de Acosta, Sabino Riestra, Margalida Calafat, et al.
Therapeutic Advances in Gastroenterology|January 8, 2024
Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registryMargalida Calafat, Paola Torres, Joan Tosca-Cuquerella, et al.
Gut|July 19, 2023
Bismuth quadruple three-in-one single capsule three times a day increases effectiveness compared with the usual four times a day schedule: results from the European Registry on <i>Helicobacter pylori</i> Management (Hp-EuReg)Ángeles Pérez-Aisa, Olga P Nyssen, Alma Keco-Huerga, et al.
Frontiers in Medicine|February 18, 2022
Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native PatientsAna Gutiérrez, Pedro Zapater, Elena Ricart, et al.
Pageof 43